![](/img/cover-not-exists.png)
Investigation of Regional Mechanisms Responsible for Poor Oral Absorption in Humans of a Modified Release Preparation of the -Adrenoreceptor Antagonist, 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): The Rational Use of ex Vivo Intestine to Predict in Vivo Absorption
Collett, A., Stephens, R. H., Harwood, M. D., Humphrey, M., Dallman, L., Bennett, J., Davis, J., Carlson, G. L., Warhurst, G.Volume:
36
Language:
english
Journal:
Drug Metabolism and Disposition
DOI:
10.1124/dmd.107.016865
Date:
October, 2007
File:
PDF, 236 KB
english, 2007